ArticleEJHaem2023

SARS-CoV-2 infection results in upregulation of Plasminogen Activator Inhibitor-1 and Neuroserpin in the lungs, and an increase in fibrinolysis inhibitors associated with disease severity.

Kevin H Toomer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.